ATE429211T1 - Flüssige trägerformulierungen mit hohem wassergehalt - Google Patents

Flüssige trägerformulierungen mit hohem wassergehalt

Info

Publication number
ATE429211T1
ATE429211T1 AT03716645T AT03716645T ATE429211T1 AT E429211 T1 ATE429211 T1 AT E429211T1 AT 03716645 T AT03716645 T AT 03716645T AT 03716645 T AT03716645 T AT 03716645T AT E429211 T1 ATE429211 T1 AT E429211T1
Authority
AT
Austria
Prior art keywords
liquid carrier
water content
high water
carrier vehicle
liquid
Prior art date
Application number
AT03716645T
Other languages
English (en)
Inventor
Siu Cowan
Donna Palmer
Original Assignee
Battelle Memorial Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Memorial Institute filed Critical Battelle Memorial Institute
Application granted granted Critical
Publication of ATE429211T1 publication Critical patent/ATE429211T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03716645T 2002-03-22 2003-03-17 Flüssige trägerformulierungen mit hohem wassergehalt ATE429211T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/104,662 US20030185762A1 (en) 2002-03-22 2002-03-22 Highly aqueous liquid carrier formulations
PCT/US2003/008157 WO2003082242A2 (en) 2002-03-22 2003-03-17 Highly aqueous liquid carrier formulations

Publications (1)

Publication Number Publication Date
ATE429211T1 true ATE429211T1 (de) 2009-05-15

Family

ID=28452384

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03716645T ATE429211T1 (de) 2002-03-22 2003-03-17 Flüssige trägerformulierungen mit hohem wassergehalt

Country Status (7)

Country Link
US (1) US20030185762A1 (de)
EP (1) EP1487409B1 (de)
AT (1) ATE429211T1 (de)
AU (1) AU2003220346A1 (de)
CA (1) CA2480123C (de)
DE (1) DE60327310D1 (de)
WO (1) WO2003082242A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2440763C (en) 2001-03-22 2010-05-25 Battelle Memorial Institute Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles
CN101151048A (zh) * 2004-05-10 2008-03-26 纳斯泰克制药公司 增强甲状旁腺激素粘膜递送的组合物和方法
CA2579725A1 (en) * 2004-09-14 2006-03-23 Ada S. Cowan Highly-aqueous non-respirable aerosols containing biologically-active ingredients method of making and device therefor
ES2394589T3 (es) 2007-12-14 2013-02-04 Aerodesigns, Inc Suministro de productos alimenticios transformables en aerosol
US20110174304A1 (en) * 2010-01-21 2011-07-21 Triplett Ii Michael D Electrohydrodynamic aerosolization device having a time varying voltage
EP4415708A4 (de) * 2021-10-13 2025-07-30 Pneuma Respiratory Inc Zusammensetzungen zur verabreichung von cannabinoiden

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
US5215739A (en) * 1989-04-05 1993-06-01 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
IL97075A0 (en) * 1990-02-14 1992-03-29 Alcon Lab Inc Topical pharmaceutical composition containing an alkyl saccharide
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
AU2001244391B9 (en) * 2000-04-03 2006-10-05 Ventaira Pharmaceuticals, Inc. Devices and formulations
US6339107B1 (en) * 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
WO2002043750A2 (en) * 2000-12-01 2002-06-06 Battelle Memorial Institute Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations

Also Published As

Publication number Publication date
EP1487409B1 (de) 2009-04-22
AU2003220346A1 (en) 2003-10-13
CA2480123A1 (en) 2003-10-09
CA2480123C (en) 2010-11-30
EP1487409A2 (de) 2004-12-22
WO2003082242A2 (en) 2003-10-09
US20030185762A1 (en) 2003-10-02
DE60327310D1 (de) 2009-06-04
WO2003082242A3 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
MXPA03004883A (es) Metodo para la estabilizacion de biomoleculas (por ejemplo, insulina) en formulaciones liquidas.
MX9605650A (es) Formulaciones de propionato de fluticasona.
DK1073439T3 (da) Farmaceutisk sammensætning
DE60027463D1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
DK1206261T3 (da) Farmaceutiske præparater, der omfatter clavuansyre eller derivater deraf, til behandlingen af adfærdsmæssige sygdomme
IL120317A0 (en) Otic antibacterial compositions
MX9802734A (es) Nuevas formulaciones liquidas estables a base de paracetamol y su modo de preparacion.
AR048017A1 (es) Composicion y metodo para aumentar la biodisponibilidad
UY25374A1 (es) Composiciones de apomorfina útiles en el tratamiento de disfunción sexual femenina
ATE187641T1 (de) Verfahren zum bekämpfen der pneumocystis carinii pneumonie und dafür verwendbare verbindungen
TR200103178T2 (tr) İntegrinlerin reseptörlere bağlanmasını engelleyen karboksilik asit türevleri.
EA200100298A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ С РЕГУЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ ИНГИБИТОР cGMP-ФОСФОДИЭСТЕРАЗЫ-5
NO20001567D0 (no) Bioadhesive sammensetninger og fremgangsmåter for topisk administrering av aktive midler
NO952269L (no) Stabiliserte medisinske aerosollösnings-formuleringer
ATE386506T1 (de) Verabreichung unlöslicher arzneistoffe
DE69414840D1 (de) Akzeptabele pharmazeutische zusammensetzung enthaltend einen alkohol und einen hydrophalischen wirkstoff
ES8607721A1 (es) Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario.
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ATE450265T1 (de) Pharmazeutische mischung zur behandlung von krebs,die dioxolan nukleosidanalogen enthält
ES2151083T3 (es) Composiciones orales que contienen ondansetron.
BG106104A (en) Method for the treatment of diseases related to increased number of neutrophils or neutrophil overactivation
HK1047036A1 (zh) 用於治疗偏头痛的选择性iglur5，受体拮抗剂
DE60327310D1 (de) Flüssige trägerformulierungen mit hohem wassergehalt
SI1684719T1 (sl) Sestavki alfa antitripsina in postopki zdravljenja ob uporabi takih sestavkov
CO5190664A1 (es) Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties